An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.
Medical Terms & Definitions Glossary
An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.
Medical Terminology DB · Copyright © 2025 · Privacy · Terms of Use · Disclaimer · XML Sitemap
Leave a Comment
You must be logged in to post a comment.